Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Universität Münster currently manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 2 distinct examiners across 2 distinct art units. This 1-to-1 ratio between actions, examiners, and art units suggests a prosecution effort where each case is treated as a unique technical matter.
The busiest examiner is STONEBRAKER, ALYSSA RAE, who is responsible for 1 pending office action. With 2 pending office actions in total, the workload is split between the 2 distinct examiners. This distribution means that each pending matter in the Biotechnology & Pharmaceuticals sector is being reviewed by a different technical expert in a separate art unit. For the university, this requires coordinating with 2 distinct examiners within their respective 2 distinct art units. This lack of concentration ensures that the outcome of 1 office action is less likely to directly influence the other through examiner overlap.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STONEBRAKER, ALYSSA RAE | 1 | 58.3% | +49.2% |
| VANN-OJUEKAIYE, KENDRA RAYCHELL | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17622149 | METHOD FOR ESTABLISHING AN INDIVIDUAL PHYSICAL ACTIVITY PROGRAM FOR A SUBJECT FOR REDUCING AN INDIVIDUAL RISK OF THE SUBJECT FOR DEVELOPING A CARDIOVASCULAR DISEASE | VANN-OJUEKAIYE, KENDRA RAYCHELL | 132d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039946 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | STONEBRAKER, ALYSSA RAE | — |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039946 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | STONEBRAKER, ALYSSA RAE | 1642 | §103§112DP | Non-Final OA | — | Pending | Jun 01, 2023 |
| 17622149 | METHOD FOR ESTABLISHING AN INDIVIDUAL PHYSICAL ACTIVITY PROGRAM FOR A SUBJECT FOR REDUCING AN INDIVIDUAL RISK OF THE SUBJECT FOR DEVELOPING A CARDIOVASCULAR DISEASE | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §101§103§112 | Non-Final OA | 132d overdue | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial